Successful treatment of a 12-year-old boy with Guillain-Barré syndrome requiring tracheostomy due to respiratory muscle paralysis: A case report
- PMID: 32010274
- PMCID: PMC6966195
- DOI: 10.3892/etm.2019.8311
Successful treatment of a 12-year-old boy with Guillain-Barré syndrome requiring tracheostomy due to respiratory muscle paralysis: A case report
Abstract
Childhood Guillain-Barré syndrome (GBS) occasionally leads to respiratory failure early after onset, requiring long-term ventilation management after tracheal intubation. However, patients requiring tracheostomy management are rare. In the present study, a case of a 12-year-old boy with GBS who required artificial respiration management due to rapid progression of respiratory muscle paralysis is reported. Intravenous immunoglobulin (IVIg) and pulse steroid therapy were provided; however, both were ineffective and tracheostomy was necessary 26 days after onset. A second course of IVIg and pulse steroid therapy was administered on day 34. With continued rehabilitation, the patient was able to walk long distances on day 74 and was subsequently discharged on day 89. In cases of severe GBS, when IVIg and pulse steroid therapy do not improve the respiratory muscle strength of the patient, early tracheostomy may improve the patient's quality of life during artificial respiration management.
Keywords: Guillain-Barré syndrome; children; immunoglobulin; steroid pulse; tracheostomy.
Copyright © 2020, Spandidos Publications.
Figures
Similar articles
-
Cryptosporidiosis - A Plausible Cause for Relapse of Guillain-Barré Syndrome.Cureus. 2021 Apr 23;13(4):e14652. doi: 10.7759/cureus.14652. Cureus. 2021. PMID: 34046283 Free PMC article.
-
Intravenous immunoglobulin in very severe childhood Guillain-Barré syndrome.Ann Trop Paediatr. 1999 Jun;19(2):167-74. doi: 10.1080/02724939992491. Ann Trop Paediatr. 1999. PMID: 10690257
-
Albumin levels as a biomarker for second Intravenous Immunoglobulin (IVIG) treatment in Guillain-Barre syndrome (GBS).J Clin Neurosci. 2020 Apr;74:247-249. doi: 10.1016/j.jocn.2020.01.067. Epub 2020 Feb 20. J Clin Neurosci. 2020. PMID: 32088107
-
Diagnosis, treatment and prognosis of Guillain-Barré syndrome (GBS).Presse Med. 2013 Jun;42(6 Pt 2):e193-201. doi: 10.1016/j.lpm.2013.02.328. Epub 2013 Apr 28. Presse Med. 2013. PMID: 23628447 Review.
-
Intensive Care and Treatment of Severe Guillain-Barré Syndrome.Front Pharmacol. 2021 Apr 27;12:608130. doi: 10.3389/fphar.2021.608130. eCollection 2021. Front Pharmacol. 2021. PMID: 33995011 Free PMC article. Review.
References
-
- Walgaard C, Jacobs BC, Lingsma HF, Steyerberg EW, Cornblath DR, van Doorn PA, van Doorn PA, Jacobs BC, Walgaard C, de Wit MC, et al. Dutch GBS Study Group Second IVIg course in Guillain-Barré syndrome patients with poor prognosis (SID-GBS trial): Protocol for a double-blind randomized, placebo-controlled clinical trial. J Peripher Nerv Syst. 2018;23:210–215. doi: 10.1111/jns.12286. - DOI - PubMed
LinkOut - more resources
Full Text Sources